Blue Jet Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050

Blue Jet Healthcare is a global company that makes special chemicals needed to create different medicines. It works as a CDMO, which means it helps other pharma companies by developing and producing these important ingredients for them. The company is known for making chemicals used in medical scans, sweeteners like saccharin, and many other key medicine ingredients, and it supplies these products to more than 400 customers in 39 countries. It has many years of experience and strong skills in making these products. The company focuses on simple, niche, and high-quality work that helps other companies make safe and effective medicines.

What is Blue Jet Healthcare Ltd NSE: BLUEJET?

Blue Jet Healthcare was established in 1968 in Maharashtra, India, and was founded by B.D. Jetwani. It makes chemicals used to make medicines. The company works for other pharma companies by helping them develop and produce important ingredients. It makes chemicals used in medical scanning tests, sweeteners like saccharin, and many ingredients needed to make different medicines. Over the years, it has grown from a small sweetener maker to a well-known company that supplies good-quality products to many big companies around the world through its modern factories in Maharashtra.

Blue Jet Healthcare Share Price Target

Blue Jet Healthcare Share Price Target 2025

In the early days, the company made simple chemicals and sold them to nearby businesses. After some time, the founders realised they could grow faster if they made more advanced and special products. Their first big success came when they started making saccharin, a very strong and popular sweetener. This helped them become well-known in India and other countries. Because they always focused on good quality and kept improving their work, the company slowly grew from a small chemical factory into a trusted global supplier that many companies depend on today. In 2025, its share price target would be ₹1027, as per stock market analysts.

Its share price would be between ₹460 to ₹1027 in 2025, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	674	1027

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	534	758
February	723	844
March	752	968
April	625	863
May	692	909
June	847	986
July	755	1027
August	659	825
September	628	780
October	630	692
November	538	688
December	460	740

Blue Jet Healthcare Share Price Target 2026

Later, the company changed its business direction and became a CDMO, which means Contract Development and Manufacturing Organisation. This simply means the company helps other pharma companies by making the important chemical ingredients needed for medicines. They do not make final medicines themselves. Instead, they make the special chemical parts used to create those medicines. This way of working helped them build strong partnerships with global pharma companies and grow quickly. In 2026, its share price target would be ₹1500, as per stock market analysts.

Its share price would be between ₹674 to ₹1500 in 2026, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	674	1500

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	674	830
February	700	955
March	747	985
April	832	1055
May	887	1084
June	932	1142
July	945	1174
August	990	1200
September	1055	1254
October	1154	1325
November	1251	1433
December	1355	1500

Share Price Target 2027

It has been a leading maker of high-intensity sweeteners for many years. Their most well-known sweetener is saccharin, which has zero calories and is used in many everyday products. It is found in toothpaste, mouthwash, diet drinks, baked foods, and even some medicines. Since saccharin is much sweeter than sugar, only a very small amount is needed, making it cheap and useful. Because it started making saccharin early and always kept the quality high, many food and FMCG companies around the world trust me as a top supplier. In 2027, its share price target would be ₹1960, as per stock market analysts.

Its share price would be between ₹1412 to ₹1960 in 2027, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	1412	1960

Share Price Target 2028

Another major part of the company’s work is making pharmaceutical intermediates. These are special chemicals used to make many types of medicines. They act like building blocks for drugs that treat cancer, heart problems, infections, and brain disorders. The company uses advanced techniques to make these chemicals safely and with very high purity. Their strong chemical knowledge helps both new drug makers and companies that produce generic medicines. In 2028, its share price target would be ₹2408, as per stock market analysts.

Its share price would be between ₹1860 to ₹2408 in 2028, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	1860	2408

Share Price Target 2029

It has built a large group of more than 400 customers from 39 countries. These include big pharma companies, major FMCG brands, and global leaders in medical imaging. Their success comes from giving high-quality products, delivering on time, and always following international safety and quality rules. Because many of their clients work in sensitive fields where mistakes can cause big problems, they trust this company for its reliability. In 2029, its share price target would be ₹2857, as per stock market analysts.

Its share price would be between ₹2290 to ₹2857 in 2029, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	2290	2857

Blue Jet Healthcare share price Target 2030

The company has modern factories in Maharashtra, located in Shahad, Ambernath, and Mahad. These factories have advanced machines, special reactors, testing labs, and strong safety systems to ensure safe and clean production. They follow global standards like WHO-GMP and ISO to maintain high quality. With several factories, the company can produce different products in large amounts without affecting quality. Their plants are designed to handle complex chemical processes, which helps them make special ingredients for medicine, food, and healthcare products for customers worldwide. In 2030, its share price target would be ₹3306, as per stock market analysts.

Its share price would be between ₹2780 to ₹3306 in 2030, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	2780	3306

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	2780	2925
February	2805	2984
March	2832	3022
April	2850	3056
May	2868	3078
June	2884	3090
July	2932	3135
August	2960	3157
September	2978	3174
October	2990	3190
November	3025	3255
December	3120	3306

Share Price Target 2040

Research and Development (R&D) is one of the main strengths of the company. The company has advanced labs where skilled scientists work on making new chemical processes, improving existing products, and finding better ways to manufacture complex ingredients. Their R&D team helps them stay updated with global changes and meet the increasing demand for special pharma chemicals. They can also create unique products for clients who need something specific. In 2040, its share price target would be ₹5443, as per stock market analysts.

Its share price would be between ₹4968 to ₹5443 in 2040, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	4968	5443

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	4968	5085
February	4980	5123
March	5011	5157
April	5057	5184
May	5089	5210
June	5132	5235
July	5150	5257
August	5175	5275
September	5189	5321
October	5210	5359
November	5256	5390
December	5275	5443

Share Price Target 2050

This company always tries to understand what its customers want. Instead of selling one standard product to everyone, they create special ingredients based on each customer’s needs. This helps customers save time, reduce production costs, and improve product quality. Their flexible working style and willingness to try new solutions make them a preferred partner for many international companies. It ensures customers always receive a reliable supply, steady support, and high-quality products every time. In 2050, its share price target would be ₹7856, as per stock market analysts.

Its share price would be between ₹7344 to ₹7856 in 2050, as per stock market analysts.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	7344	7856

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	7344	7490
February	7387	7532
March	7400	7557
April	7432	7574
May	7450	7590
June	7475	7632
July	7490	7658
August	7511	7678
September	7534	7689
October	7565	7735
November	7580	7760
December	7660	7856

Should I buy Blue Jet Healthcare stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	674	1027
2026	674	1500
2027	1412	1960
2028	1860	2408
2029	2290	2857
2030	2780	3306
2040	4968	5443
2050	7344	7856

It could be a good choice for some investors because it makes important products like chemicals for medicines and sweeteners, works with many global clients, and has the potential to grow in the future. Analysts have given positive price targets, showing possible gains. However, the stock also has risks, like recent drops in profits, ups and downs in share price, and reliance on global demand for pharma products. It could be a good choice if you want long-term growth and can handle some risk.

Blue Jet Healthcare earnings results

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales +	538	499	683	721	712	1,030	1,179
Expenses +	325	292	434	502	481	652	739
Operating Profit	214	207	249	219	231	378	440
OPM %	40%	41%	36%	30%	32%	37%	37%
Other Income +	6	9	19	24	18	46	58
Interest	7	5	3	1	0	0	5
Depreciation	18	20	22	25	28	18	21
Profit before tax	194	190	243	217	220	406	471
Tax %	25%	26%	25%	26%	26%	25%
Net Profit +	145	142	182	160	164	305	352
EPS in Rs	24,118.33	1,428.77	10.47	9.23	9.44	17.59	20.33
Dividend Payout %	0%	0%	0%	0%	11%	7%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
26.95	8.38	0.22%	36.32	5.73	0.59%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Blue Jet Healthcare Ltd	31.12	8.38	0.22%
Sun Pharmaceutical Industries Ltd	38.99	5.88	0.90%
Torrent Pharmaceuticals Ltd	66.65	16.78	0.85%
Cipla Ltd	22.84	3.85	1.07%

Is Blue Jet Healthcare stock good to buy? (bull case & bear case)

Bull Case:

• In FY2025, its net sales went up from ₹7,116 million in FY2024 to ₹10,300 million.
• Its profit after tax (PAT) increased from ₹1,638 million in FY2024 to ₹3,052 million in FY2025.
• The net profit margin went up from about 23.0% in FY2024 to around 29.6% in FY2025, which means the company is managing costs better and earning more from sales.
• The company works with more than 400 customers in 39 countries, which helps reduce dependence on any single client or market.
• It has three modern factories (Shahad, Ambernath, and Mahad), which help it make more products and meet global demand.
• Its business model as a CDMO and maker of speciality chemicals (contrast-media chemicals, sweeteners, pharma ingredients) makes it a trusted supplier and hard for competitors to replace.

Bear Case:

• In Q1 FY26, revenue was ₹354.76 crore, but net profit dropped 17% quarter-on-quarter to ₹91.17 crore.
• The company depends on global demand for pharma ingredients. If demand falls or raw-material costs rise, profits could be lower.
• A large part of the event comes from a few big clients. Losing one of them could reduce overall sales a lot.
• Demand for speciality APIs and contrast-media chemicals may change with global healthcare spending. During economic slowdowns, orders could drop and affect revenue.

Conclusion

It is a global company that makes important chemicals for medicines, like chemicals used in medical scans, sweeteners like saccharin, and other medicine ingredients. It works with many clients in different countries. Over the years, it has grown steadily, improved profits, and built strong relationships with global clients. Although it has good growth potential, it faces risks like changes in global demand, rising raw-material costs, and reliance on major clients. Overall, it is seen as a good stock for long-term investors who can handle some risk.

FAQs